Things I read yesterday as part of my stock research activities.
New Orders Received
🟢 VA Tech Wabag won a large order from BPCL worth ₹250 to ₹600 Cr for Bina refinery expansion water treatment. 22-month timeline.
🔴 Railtel said Bihar Education Project Council has cancelled the LOA and work order for its Bihar smart classroom project worth about ₹262.14 crore, citing unavoidable reasons from the customer’s side.
🟢 Interarch Building Solutions received a domestic order of about ₹130 crore for complete design, engineering, manufacturing, supply and erection of a pre-engineered steel building system, executable in 17 months.
🟢 M&B Engineering secured a domestic ₹63.50 Cr order for pre-engineered buildings and structural steel, to be completed within 8.5 months.
Core Business & Regulatory
🟢 Dynamatic Technologies delivered its first complete ship-set of 8 Airbus A220 doors ahead of schedule.
🟢 Omaxe announced a ₹500 Cr investment to develop Omaxe Chowk, a 5.25-acre luxury residential and retail project in Ludhiana, targeted for completion by June 2030.
🟢 Metropolis Healthcare launched a Centre of Genomics using Illumina NovaSeq X, expanding advanced tests from 220 to over 500 to scale precision diagnostics.
🟢 Zydus Lifesciences said subsidiary Sentynl received US FDA approval for ZYCUBO for Menkes disease, noting trial data showed 80% mortality risk reduction.
Economy, IPO & Other
🔴 Delivery apps saw scrutiny as reports said 10-minute delivery deadlines were removed. Due to safety concerns for delivery partners.
That’s it for today.
FINVEZTO.COM | Build Wealth. With Clarity.
At Finvezto Stock Research (Anand Ganapathy, SEBI Registered RA), we offer the following services. Do check out more details at finvezto.com.
Balanced Asset Allocation (Core Portfolio)
Quality Stocks in Momentum (Satellite Portfolio)
Short Term Strategies (Overlay Portfolio)
Advanced Tools for Stock Research (Research For DIY Investors & Traders)
Disclaimer: Anand Ganapathy K is a SEBI-registered Research Analyst with SEBI registration number INH000016630. This post is purely for learning purposes to understand more about the business. It does not recommend buying or selling stocks mentioned in this newsletter. Securities market investments carry market risks. Kindly review all related documents before investing.